Back
Alvotech 10K Form
Sell
16
ALVO
Alvotech
Last Price:
11.60
Seasonality Move:
32.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALVO News And Ratings
See the #1 stock for the next 7 days that we like better than ALVO
ALVO Financial Statistics
Sales & Book Value
| Annual Sales: | $91.43M |
|---|---|
| Cash Flow: | $-85.89M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-1.14 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.85000 |
|---|---|
| Net Income (TTM): | $-441.45M |
| Gross Margin: | $-69.42M |
| Return on Equity: | 0% |
| Return on Assets: | -41.88% |
Alvotech Earnings Forecast
Key Alvotech Financial Ratios
- The Gross Profit Margin over the past 4 years for ALVO is -75.93%.
- The Selling, General & Administrative Expenses for ALVO have been equal to 83.73% of Gross Profit Margin.
- The Research & Development expenses have been 230.58% of Revenue.
- The Interest Expense is -24.14% of Operating Income.
- The Net Earning history of ALVO is -603.42% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 3 years.
Alvotech Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ALVO |
| Website: | alvotech.com |
Debt
| Debt-to-Equity Ratio: | -2.99 |
|---|---|
| Current Ratio: | 2.69 |
| Quick Ratio: | 1.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 44.68 |